Close Menu

NEW YORK – The Centers for Medicare and Medicaid Services and the US Departments of Labor and the Treasury on Saturday issued guidance requiring private health insurance to cover, at no cost, diagnostic testing for SARS-CoV-2, the coronavirus that causes COVID-19.

The guidance covers molecular-based testing, as well as serology tests.

Under the guidance, group health plans and group and individual health insurers must cover diagnostic testing and "certain related items and services" during a medical visit without any cost sharing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.